Photo of G. Scott Gazelle,  MD, MPH, PhD

G. Scott Gazelle, MD, MPH, PhD

Massachusetts General Hospital

Massachusetts General Hospital
Phone: (617) 726-4047
Fax: (617) 726-9414


scott@mgh-ita.org

G. Scott Gazelle, MD, MPH, PhD

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Professor, Radiology, Harvard Medical School
  • Professor, Health Policy and Management, Harvard T.H. Chan School Of Public Health
  • Director, Institute for Technology Assessment, Massachusetts General Hospital
  • Director, Partners Radiology, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

Dr. Gazelle's research focuses on the evaluating the benefits, costs, and appropriate use of new medical technologies. He also directs the DF/HCC Program in Cancer Outcomes Research Training, which provides fellowship training for individuals interesting in cancer outcomes research.

Publications

Powered by Harvard Catalyst
  • Harvey HB, Alkasab TK, Pandharipande PV, Zhao J, Halpern EF, Salazar GM, Abujudeh HH, Rosenthal DI, Gazelle GS. Radiologist compliance with institutional guidelines for use of nonroutine communication of diagnostic imaging results. J Am Coll Radiol 2015; 12:376-84. PubMed
  • Romanus D, Cardarella S, Cutler D, Landrum MB, Lindeman NI, Gazelle GS. Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer. J Thorac Oncol 2015; 10:586-94. PubMed
  • Glover M, Khalilzadeh O, Choy G, Prabhakar AM, Pandharipande PV, Gazelle GS. Hospital Evaluations by Social Media: A Comparative Analysis of Facebook Ratings among Performance Outliers. J Gen Intern Med 2015. PubMed
  • Lowry KP, Gazelle GS, Gilmore ME, Johanson C, Munshi V, Choi SE, Tramontano AC, Kong CY, McMahon PM. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis. Cancer 2015. PubMed
  • Niell BL, Bennett D, Sharma A, Gazelle GS. Extramammary Findings on Breast MR Examinations: Frequency, Clinical Relevance, and Patient Outcomes. Radiology 2015. PubMed
  • Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, Gazelle GS, Weinstein MC. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer 2014; 120:1345-52. PubMed
  • Tramontano AC, Cipriano LE, Kong CY, Shepard JA, Lanuti M, Gazelle GS, McMahon PM. Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer. AJR Am J Roentgenol 2013; 200:1020-7. PubMed
  • Cott Chubiz JE, Lee JM, Gilmore ME, Kong CY, Lowry KP, Halpern EF, McMahon PM, Ryan PD, Gazelle GS. Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer 2013; 119:1266-76. PubMed
  • Pandharipande PV, Eisenberg JD, Lee RJ, Gilmore ME, Turan EA, Singh S, Kalra MK, Liu B, Kong CY, Gazelle GS. Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox. Radiology 2013; 266:896-904. PubMed
  • Knudsen AB, Hur C, Gazelle GS, Schrag D, McFarland EG, Kuntz KM. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med 2012; 157:611-20. PubMed
  • Hartman RI, Chang CY, Wo JY, Eisenberg JD, Hong TS, Harisinghani MG, Gazelle GS, Pandharipande PV. Optimizing Adjuvant Treatment Decisions for Stage T2 Rectal Cancer Based on Mesorectal Node Size: A Decision Analysis. Acad Radiol 2012. PubMed
  • McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS. Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal 2012; 32 Suppl 1:S117-24. PubMed
  • Abujudeh HH, Kaewlai R, McMahon PM, Binder W, Novelline RA, Gazelle GS, Thrall JH. Abdominopelvic CT increases diagnostic certainty and guides management decisions: a prospective investigation of 584 patients in a large academic medical center. AJR Am J Roentgenol 2011; 196:238-43. PubMed
  • Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 2011; 16:121-32. PubMed
  • Cipriano LE, Romanus D, Earle CC, Neville BA, Halpern EF, Gazelle GS, McMahon PM. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health 2011; 14:41-52. PubMed
  • Pandharipande PV, Gervais DA, Hartman RI, Harisinghani MG, Feldman AS, Mueller PR, Gazelle GS. Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology 2010; 256:836-46. PubMed
  • Abujudeh HH, Boland GW, Kaewlai R, Rabiner P, Halpern EF, Gazelle GS, Thrall JH. Abdominal and pelvic computed tomography (CT) interpretation: discrepancy rates among experienced radiologists. Eur Radiol 2010; 20:1952-7. PubMed
  • Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. 2010; 23:451-7. PubMed
  • Ho W, Broughton DE, Donelan K, Gazelle GS, Hur C. Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population. AJR Am J Roentgenol 2010; 195:393-7. PubMed
  • Blankstein R, Murphy MK, Nasir K, Gazelle GS, Batlle JC, Al-Mallah M, Shturman L, Hoffmann U, Cury RC, Abbara S, Brady TJ, Lee TH. Perceived usefulness of cardiac computed tomography as assessed by referring physicians and its effect on patient management. Am J Cardiol 2010; 105:1246-53. PubMed
  • Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology 2010; 254:793-800. PubMed
  • Huang ES, Gazelle GS, Hur C. Consensus Guidelines in the Management of Branch Duct Intraductal Papillary Mucinous Neoplasm: A Cost-Effectiveness Analysis. Dig Dis Sci 2010; 55:852-60. PubMed
  • Hur C, Hayeck TJ, Yeh JM, Richards EB, Spechler SJ, Gazelle GS, Kong CY. Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS ONE 2010; 5:e9483. PubMed
  • Ladapo JA, Jaffer FA, Hoffmann U, Thomson CC, Bamberg F, Dec W, Cutler DM, Weinstein MC, Gazelle GS. Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol 2010; 54:2409-22. PubMed
  • Pandharipande PV, Gazelle GS. Comparative effectiveness research: what it means for radiology. Radiology 2009; 253:600-5. PubMed
  • Lee JM, Halpern EF, Rafferty EA, Gazelle GS. Evaluating the correlation between film mammography and MRI for screening women with increased breast cancer risk. Acad Radiol 2009; 16:1323-8. PubMed
  • Greenblatt WH, Hur C, Knudsen AB, Evans JA, Chung DC, Gazelle GS. Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 2009; 18:2677-84. PubMed
  • Hur C,Broughton DE,Kong CY,Ozanne EM,Richards EB,Truong T,Gazelle GS. Patient Preferences for the Chemoprevention of Colorectal Cancer. Dig Dis Sci 2009; 54:2207-14. PubMed
  • Pandharipande PV, Mora JT, Uppot RN, Goehler A, Braschi M, Halpern EF, Gazelle GS, Harisinghani MG. Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model. AJR Am J Roentgenol 2009; 193:W230-7. PubMed
  • Kahlon P, McCullough K, Gazelle GS. Enhancing patient safety: standardization of CT contrast media practices. J Am Coll Radiol 2009; 6:562-6. PubMed
  • Geisler BP, van Dam RM, Gazelle GS, Goehler A. Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure. Heart 2009; 95:1278-9; author reply 1279. PubMed
  • Kong CY, McMahon PM, Gazelle GS. Calibration of disease simulation model using an engineering approach. Value Health 2009; 12:521-9. PubMed
  • Pandharipande PV,Choy G,del Carmen MG,Gazelle GS,Russell AH,Lee SI. MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes. AJR Am J Roentgenol 2009; 192:802-14. PubMed
  • McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS. Adopting helical CT screening for lung cancer : potential health consequences during a 15-year period. Cancer 2008; 113:3440-9. PubMed
  • Pandharipande PV,Harisinghani MG,Ozanne EM,Specht MC,Hur C,Lee JM,Gazelle GS. Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol 2008; 191:1308-19. PubMed
  • Pearson SD,Knudsen AB,Scherer RW,Weissberg J,Gazelle GS. Assessing the comparative effectiveness of a diagnostic technology: CT colonography. Health Aff (Millwood) 2008; 27:1503-14. PubMed
  • Hur C,Broughton DE,Ozanne E,Yachimski P,Nishioka NS,Gazelle GS. Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 2008; 103:2432-42. PubMed
  • Lee JM,Georgian-Smith D,Gazelle GS,Halpern EF,Rafferty EA,Moore RH,Yeh ED,D'Alessandro HA,Hitt RA,Kopans DB. Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions. Radiology 2008; 248:398-405. PubMed
  • Pandharipande PV, Gervais DA, Mueller PR, Hur C, Gazelle GS. Radiofrequency Ablation versus Nephron-sparing Surgery for Small Unilateral Renal Cell Carcinoma: Cost-effectiveness Analysis. Radiology 2008; 248:169-78. PubMed
  • McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS. Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study. Radiology 2008; 248:278-87. PubMed
  • Lee JM, Kopans DB, McMahon PM, Halpern EF, Ryan PD, Weinstein MC, Gazelle GS. Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis. Radiology 2008; 246:763-71. PubMed
  • Gazelle G. Understanding hospice--an underutilized option for life's final chapter. N Engl J Med 2007; 357:321-4. PubMed
  • Hur C, Chung DC, Schoen RE, Gazelle GS. The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol 2007; 5:237-44. PubMed
  • Knudsen AB, McMahon PM, Gazelle GS. Use of modeling to evaluate the cost-effectiveness of cancer screening programs. J Clin Oncol 2007; 25:203-8. PubMed
  • McMahon PM, Zaslavsky AM, Weinstein MC, Kuntz KM, Weeks JC, Gazelle GS. Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Med Decis Making 2006; 26:497-511. PubMed
  • Hur C, Wittenberg E, Nishioka NS, Gazelle GS. Quality of life in patients with various Barretts esophagus associated health states. Health Qual Life Outcomes 2006; 4:45. PubMed
  • Rodr. Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg 2006; 141:361-5; discussion 366. PubMed
  • Sahani DV, Kadavigere R, Blake M, Fernandez-Del Castillo C, Lauwers GY, Hahn PF. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP. Radiology 2006; 238:560-9. PubMed
  • Hur C, Gazelle GS, Hsu EH, Halpern EF, Podolsky DK. The effect of prior colonic imaging on endoscopic productivity: potential impact of computed tomographic colonography. Clin Gastroenterol Hepatol 2005; 3:1124-7. PubMed
  • Gazelle GS, McMahon PM, Siebert U, Beinfeld MT. Cost-effectiveness analysis in the assessment of diagnostic imaging technologies. Radiology 2005; 235:361-70. PubMed
  • Hur C, Simon LS, Gazelle GS. Analysis of aspirin-associated risks in healthy individuals. Ann Pharmacother 2004; 39:51-7. PubMed
  • Hur C, Wittenberg E, Nishioka NS, Gazelle GS. Patient preferences for the management of high-grade dysplasia in Barrett's esophagus. Dig Dis Sci 2005; 50:116-25. PubMed
  • Neumann PJ, Divi N, Beinfeld MT, Levine BS, Keenan PS, Halpern EF, Gazelle GS. Medicare's national coverage decisions, 1999-2003: quality of evidence and review times. Health Aff (Millwood) 2005; 24:243-54. PubMed
  • Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology 2004; 233:729-39. PubMed
  • Earle CC, Kwok A, Gazelle GS, Fuchs CS. Two schedules of second-line irinotecan for metastatic colon carcinoma. Cancer 2004; 101:2533-9. PubMed
  • Roberts TG, Goulart BH, Squitieri L, Stallings SC, Halpern EF, Chabner BA, Gazelle GS, Finkelstein SN, Clark JW. Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA 2004; 292:2130-40. PubMed
  • Hur C, Gazelle GS, Zalis ME, Podolsky DK. An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology 2004; 127:1312-21. PubMed
  • Hur C, Simon LS, Gazelle GS. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals. Cancer 2004; 101:189-97. PubMed
  • Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst 2004; 96:316-25. PubMed
  • Gazelle GS, Seltzer SE, Judy PF. Assessment and validation of imaging methods and technologies. Acad Radiol 2003; 10:894-6. PubMed
  • Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci 2003; 48:1273-83. PubMed
  • Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 2003; 97:3027-35. PubMed
  • Hunink MG, Gazelle GS. CT screening: a trade-off of risks, benefits, and costs. J Clin Invest 2003; 111:1612-9. PubMed
  • Gazelle GS, Hunink MG, Kuntz KM, McMahon PM, Halpern EF, Beinfeld M, Lester JS, Tanabe KK, Weinstein MC. Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Ann Surg 2003; 237:544-55. PubMed
  • Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226:441-51. PubMed
  • Halpern EF, Gazelle GS. Probability in radiology. Radiology 2003; 226:12-5. PubMed
  • Bosch JL, Halpern EF, Gazelle GS. Comparison of preference-based utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after treatment of patients with intermittent claudication. Med Decis Making 2002; 22:403-9. PubMed
  • McMahon PM, Gazelle GS. Colorectal cancer screening issues: a role for CT colonography? Abdom Imaging 2002; 27:235-43. PubMed
  • Goldberg SN, Girnan GD, Lukyanov AN, Ahmed M, Monsky WL, Gazelle GS, Huertas JC, Stuart KE, Jacobs T, Torchillin VP, Halpern EF, Kruskal JB. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 2002; 222:797-804. PubMed
  • Gazelle GS, Dunnick NR. Subsidizing radiology research. Acad Radiol 2002; 9:195-7. PubMed
  • Shaffer DW, Kigin CM, Kaput JJ, Gazelle GS. What is digital medicine? Stud Health Technol Inform 2002; 80:195-204. PubMed
  • McMahon PM, Halpern EF, Fernandez-del Castillo C, Clark JW, Gazelle GS. Pancreatic cancer: cost-effectiveness of imaging technologies for assessing resectability. Radiology 2001; 221:93-106. PubMed
  • McMahon PM, Bosch JL, Gleason S, Halpern EF, Lester JS, Gazelle GS. Cost-effectiveness of colorectal cancer screening. Radiology 2001; 219:44-50. PubMed
  • Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217:633-46. PubMed
  • McMahon PM, Araki SS, Neumann PJ, Harris GJ, Gazelle GS. Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease. Radiology 2000; 217:58-68. PubMed
  • Halpern EF, Weinstein MC, Hunink MG, Gazelle GS. Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Decis Making 2000; 20:314-22. PubMed
  • Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000; 88:2452-63. PubMed
  • Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174:323-31. PubMed
  • Geisler BP,Siebert U,Gazelle GS,Cohen DJ,Gohler A. Deterministic Sensitivity Analysis for First-Order Monte Carlo Simulations: A Technical Note. Value Health 2009; 12:96-7. PubMed
  • Ladapo JA, Horwitz JR, Weinstein MC, Gazelle GS, Cutler DM. Adoption and spread of new imaging technology: a case study. Health Aff (Millwood) 2009; 28:w1122-32. PubMed
  • Goldberg SN, Hahn PF, Halpern EF, Fogle RM, Gazelle GS. Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998; 209:761-7. PubMed
  • Goldberg SN, Hahn PF, McGovern FJ, Fogle RM, Mueller PR, Gazelle GS. Benign prostatic hyperplasia: US-guided transrectal urethral enlargement with radio frequency--initial results in a canine model. Radiology 1998; 208:491-8. PubMed
  • Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 1998; 171:201-4. PubMed
  • Goldberg SN, Gazelle GS, Solbiati L, Livraghi T, Tanabe KK, Hahn PF, Mueller PR. Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 1998; 170:1023-8. PubMed
  • Steiner P, Botnar R, Dubno B, Zimmermann GG, Gazelle GS, Debatin JF. Radio-frequency-induced thermoablation: monitoring with T1-weighted and proton-frequency-shift MR imaging in an interventional 0.5-T environment. Radiology 1998; 206:803-10. PubMed
  • Lewin JS, Connell CF, Duerk JL, Chung YC, Clampitt ME, Spisak J, Gazelle GS, Haaga JR. Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 1998; 8:40-7. PubMed
  • Solbiati L, Goldberg SN, Ierace T, Livraghi T, Meloni F, Dellanoce M, Sironi S, Gazelle GS. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997; 205:367-73. PubMed
  • Steiner P, Botnar R, Goldberg SN, Gazelle GS, Debatin JF. Monitoring of radio frequency tissue ablation in an interventional magnetic resonance environment. Preliminary ex vivo and in vivo results. Invest Radiol 1997; 32:671-8. PubMed
  • De Sanctis JT, Lee MJ, Gazelle GS, Boland GW, Halpern EF, Saini S, Mueller PR. Prognostic indicators in acute pancreatitis: CT vs APACHE II. Clin Radiol 1997; 52:842-8. PubMed
  • Goldberg SN, Ryan TP, Hahn PF, Schima W, Dawson SL, Lawes KR, Mueller PR, Gazelle GS. Transluminal radiofrequency tissue ablation with use of metallic stents. J Vasc Interv Radiol 1997; 8:835-43. PubMed
  • Hahn PF, Gazelle GS, Jiang DY, Compton CC, Goldberg SN, Mueller PR. Liver tumor ablation: real-time monitoring with dynamic CT. Acad Radiol 1997; 4:634-8. PubMed
  • McDowell RK, Gazelle GS, Murphy BL, Boland GW, Mayo-Smith WW, Warshaw AL, Mueller PR. Mucinous ductal ectasia of the pancreas. J Comput Assist Tomogr 1997; 21:383-8. PubMed
  • Livraghi T, Goldberg SN, Monti F, Bizzini A, Lazzaroni S, Meloni F, Pellican. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202:205-10. PubMed
  • Trubetskoy VS, Gazelle GS, Wolf GL, Torchilin VP. Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for X-ray computed tomography. J Drug Target 1997; 4:381-8. PubMed
  • Solbiati L, Ierace T, Goldberg SN, Sironi S, Livraghi T, Fiocca R, Servadio G, Rizzatto G, Mueller PR, Del Maschio A, Gazelle GS. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202:195-203. PubMed
  • Graf O, Gazelle GS, Kreuzer S, Halpern EF, Boehm P, Lechner G, Mueller PR. Enhancement of hepatic parenchyma, aorta, and portal vein in helical CT: comparison of iodixanol and iopromide. AJR Am J Roentgenol 1997; 168:213-7. PubMed
  • Goldberg MA, Gazelle GS, Boland GW, Hahn PF, Mayo-Smith WW, Pivovarov M, Halpern EF, Wittenberg J. Focal hepatic lesions: effect of three-dimensional wavelet compression on detection at CT. Radiology 1997; 202:159-65. PubMed
  • Goldberg SN, Gazelle GS, Compton CC, Mueller PR, McLoud TC. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol 1996; 3:929-35. PubMed
  • Wolf GL, Gazelle GS, Hamberg L, Hunter G, Rogowska J, Jiang D, Leong F. Functional computed tomography scanning with radiopaque agents: applications in the brain, kidney, and tumor of small and large mammals. Acad Radiol 1996; 3 Suppl 2:S376-8. PubMed
  • Gervais DA, Gazelle GS, Lu DS, Han PF, Mueller PR. Percutaneous transpulmonary CT-guided liver biopsy: a safe and technically easy approach for lesions located near the diaphragm. AJR Am J Roentgenol 1996; 167:482-3. PubMed
  • Hamberg LM, Hunter GJ, Halpern EF, Hoop B, Gazelle GS, Wolf GL. Quantitative high-resolution measurement of cerebrovascular physiology with slip-ring CT. AJNR Am J Neuroradiol 1996; 17:639-50. PubMed
  • Goldberg SN, Gazelle GS, Halpern EF, Rittman WJ, Mueller PR, Rosenthal DI. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3:212-8. PubMed
  • Jiang DY, Gazelle GS, Wolf GL. A model of focal cancer in rabbit lymph nodes. Acad Radiol 1996; 3:159-62. PubMed
  • Goldberg SN, Gazelle GS, Compton CC, McLoud TC. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1998; 2:776-84. PubMed
  • Gazelle GS, Wolf GL, McIntire GL, Bacon ER, Na G, Halpern EF, Toner JL. Hepatic imaging with iodinated nanoparticles: a comparison with iohexol in rabbits. Acad Radiol 1998; 2:700-4. PubMed
  • Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 1998; 2:670-4. PubMed
  • Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1998; 2:399-404. PubMed
  • Lee MJ, Mueller PR, Dawson SL, Gazelle SG, Hahn PF, Goldberg MA, Boland GW. Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. AJR Am J Roentgenol 1995; 164:215-20. PubMed
Hide